|16.66||+0.29 / +1.77%|
As of 1:00pm ET
|16.66||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +62.06% increase from the last price of 16.66.
The current consensus among 7 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.